BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23069656)

  • 1. Platelets govern pre-metastatic tumor communication to bone.
    Kerr BA; McCabe NP; Feng W; Byzova TV
    Oncogene; 2013 Sep; 32(36):4319-24. PubMed ID: 23069656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An osteoblast-derived proteinase controls tumor cell survival via TGF-beta activation in the bone microenvironment.
    Thiolloy S; Edwards JR; Fingleton B; Rifkin DB; Matrisian LM; Lynch CC
    PLoS One; 2012; 7(1):e29862. PubMed ID: 22238668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet TSP-1 controls prostate cancer-induced osteoclast differentiation and bone marrow-derived cell mobilization through TGFβ-1.
    Kerr BA; Harris KS; Shi L; Willey JS; Soto-Pantoja DR; Byzova TV
    Am J Clin Exp Urol; 2021; 9(1):18-31. PubMed ID: 33816691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.
    Vinholes J; Coleman R; Eastell R
    Cancer Treat Rev; 1996 Jul; 22(4):289-331. PubMed ID: 9025785
    [No Abstract]   [Full Text] [Related]  

  • 5. Matrix metalloproteinases as master regulators of the vicious cycle of bone metastasis.
    Lynch CC
    Bone; 2011 Jan; 48(1):44-53. PubMed ID: 20601294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
    Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
    J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension.
    Berruti A; Piovesan A; Torta M; Raucci CA; Gorzegno G; Paccotti P; Dogliotti L; Angeli A
    Br J Cancer; 1996 Jun; 73(12):1581-7. PubMed ID: 8664134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
    Koizumi M; Yonese J; Fukui I; Ogata E
    J Urol; 2002 Apr; 167(4):1863-6. PubMed ID: 11912449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bone scintigraphy for diagnosis of bone metastasis in patients with prostatic cancer].
    Nakashima J
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():135-9. PubMed ID: 12599559
    [No Abstract]   [Full Text] [Related]  

  • 10. Skeletal metastasis of prostate adenocarcinoma in rats: morphometric analysis and role of parathyroid hormone-related protein.
    Blomme EA; Dougherty KM; Pienta KJ; Capen CC; Rosol TJ; McCauley LK
    Prostate; 1999 May; 39(3):187-97. PubMed ID: 10334108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone turnover markers in tumor pathology with bone involvement].
    Napal Lecumberri J; Amado Señarís JA; Pesquera C; Riancho JA; González Macías J
    Med Clin (Barc); 1990 Apr; 94(13):487-9. PubMed ID: 2355762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Notch3 in human breast cancer cell lines regulates osteoblast-cancer cell interactions and osteolytic bone metastasis.
    Zhang Z; Wang H; Ikeda S; Fahey F; Bielenberg D; Smits P; Hauschka PV
    Am J Pathol; 2010 Sep; 177(3):1459-69. PubMed ID: 20651241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.
    Sterling JA; Edwards JR; Martin TJ; Mundy GR
    Bone; 2011 Jan; 48(1):6-15. PubMed ID: 20643235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of intratumoral platelets is associated with tumor vessel structure and metastasis.
    Li R; Ren M; Chen N; Luo M; Deng X; Xia J; Yu G; Liu J; He B; Zhang X; Zhang Z; Zhang X; Ran B; Wu J
    BMC Cancer; 2014 Mar; 14():167. PubMed ID: 24606812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone Marrow-Derived Stem Cell Factor Regulates Prostate Cancer-Induced Shifts in Pre-Metastatic Niche Composition.
    Foster BM; Shi L; Harris KS; Patel C; Surratt VE; Langsten KL; Kerr BA
    Front Oncol; 2022; 12():855188. PubMed ID: 35515124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MMP-13 is over-expressed in renal cell carcinoma bone metastasis and is induced by TGF-beta1.
    Kominsky SL; Doucet M; Thorpe M; Weber KL
    Clin Exp Metastasis; 2008; 25(8):865-70. PubMed ID: 18709334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sequential production profiles of growth factors and their relations to bone volume in ossifying bone marrow explants.
    Gurkan UA; Gargac J; Akkus O
    Tissue Eng Part A; 2010 Jul; 16(7):2295-306. PubMed ID: 20184436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone.
    Biswas S; Nyman JS; Alvarez J; Chakrabarti A; Ayres A; Sterling J; Edwards J; Rana T; Johnson R; Perrien DS; Lonning S; Shyr Y; Matrisian LM; Mundy GR
    PLoS One; 2011; 6(11):e27090. PubMed ID: 22096521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet P2Y12 is involved in murine pulmonary metastasis.
    Wang Y; Sun Y; Li D; Zhang L; Wang K; Zuo Y; Gartner TK; Liu J
    PLoS One; 2013; 8(11):e80780. PubMed ID: 24236201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-vivo analysis of the bone microenvironment in bone metastatic breast cancer.
    Bussard KM; Mastro AM
    J Mammary Gland Biol Neoplasia; 2009 Dec; 14(4):387-95. PubMed ID: 19949843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.